Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases

By Darson M.F.   Pacelli A.   Roche P.   Rittenhouse H.G.   Wolfert R.L.   Saeid M.S.   Young C.Y.F.   Klee G.G.   Tindall D.J.   Bostwick D.G.  

Urology, Vol. 53, Iss. 5, 1999-05 ,pp. : 939-944

Elsevier

Access to resources Recommend Favorite

Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels

By Charlesworth M.C.   Young C.Y.-F.   Klee G.G.   Saedi M.S.   Mikolajczyk S.D.   Finlay J.A.   Tindall D.J.  

Urology, Vol. 49, Iss. 3, 1997-05 ,pp. : 487-493

Elsevier

Access to resources Recommend Favorite

Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages

By Corey E.   Arfman E.W.   Oswin M.M.   Melchior S.W.   Tindall D.J.   Young C.Y.-F.   Ellis W.J.   Vessella R.L.  

Urology, Vol. 50, Iss. 2, 1997-08 ,pp. : 184-188

Elsevier

Access to resources Recommend Favorite

Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer

By Pannek J.   Rittenhouse H.G.   Evans C.L.   Finlay J.A.   Bruzek D.J.   Cox J.L.   Chan D.W.   Subong E.N.P.   Partin A.W.  

Urology, Vol. 50, Iss. 5, 1997-11 ,pp. : 715-721

Elsevier

Access to resources Recommend Favorite

Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis

By Partin A.W.   Catalona W.J.   Finlay J.A.   Darte C.   Tindall D.J.   Young C.Y.-F.   Klee G.G.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 5, 1999-11 ,pp. : 839-845

Elsevier

Access to resources Recommend Favorite